Search

everythinglearnresearchcommunity

for

Search:↓

New findings suggest targeting IL-23 could treat psoriasis, skin cells can adapt to new roles, direct conversion of skin cells to blood cells may aid cell therapy, removing certain tumor cells could boost cancer immunotherapy, and melanoma may have many tumorigenic cells, not just cancer stem cells.

Malondialdehyde-modified DNA may trigger an immune response in alopecia areata patients.

Minoxidil doesn't affect perifollicular lymphoid infiltration in alopecia areata patients.

Retinol may affect immune responses in people with frequent skin boils.

NKG2D gene polymorphism doesn't affect SLE risk but may influence symptoms like rash and hair loss.

Keratins are crucial for cell stability, wound healing, and cancer diagnosis.

CTA is often mistaken for AA but doesn't respond to steroids and may require hair transplantation.

Ift20 is essential for hair follicle function and skin cell movement.

Blocking Wnt signaling in young mice causes thymus shrinkage and cell loss, but recovery is possible when the block is removed.

Clinical signs don't match inflammation levels in lichen planopilaris and frontal fibrosing alopecia.

Mice studies show that Protein Phosphatase 2A is crucial for cell growth, development, and disease prevention.

The congress highlighted new gene therapy techniques and cell transplantation methods for treating diseases.

Chemotherapy may cause recurring hair loss due to an autoimmune response.

Men are more affected by COVID-19 due to differences in immune responses and protein expression.

Current treatments for alopecia areata can help hair grow but don't cure the disease.

Tofacitinib is a potential alternative treatment for alopecia totalis, especially in patients with a shorter duration of the condition and more preserved hair follicles, but the overall response rate is low.

Tofacitinib temporarily regrew hair in a man with alopecia, but its effects didn't last.

Obesity negatively affects the endometrium, leading to higher miscarriage risk and impaired cell function.

Eating vitamin A affects hair growth and health by changing cell signals in mice.

Tretinoin gel is safe for sun exposure, but tacalcitol doesn't significantly improve non-segmental vitiligo.

Combining imiquimod with diphenylcyclopropenone may improve treatment outcomes for alopecia areata patients who don't respond to diphenylcyclopropenone alone.

Tetrahydroxystilbene Glucoside may help prevent hair loss by blocking certain pathways that lead to cell death.

Rhodococcus equi causes severe pneumonia in young foals, and effective vaccines are needed due to foals' weak immune responses.

Both topical calcipotriol and narrowband UVB improved alopecia, but combining them didn't enhance the effect on hair loss severity, despite higher vitamin D3 levels.

Alopecia areata needs new treatments targeting autoimmune processes due to its emotional impact and variable treatment responses.

People with vitiligo may have a higher rate of Helicobacter pylori infection, but the infection's severity doesn't affect how severe the vitiligo is.

Higher CRHR1 levels in AA patients lead to increased inflammation.

RXRα is crucial for proper immune response and links diet to immune function.

A new treatment using a special gel with miR-665 reduces inflammation and helps hair regrow in alopecia areata.

Regulatory T cells help prevent autoimmunity and have potential for treating autoimmune diseases.